Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37226111)
Watch
English
The future of endocannabinoid-oriented clinical research after CB1 antagonists.
scientific article published on 20 March 2009
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
title
The future of endocannabinoid-oriented clinical research after CB1 antagonists
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
main subject
endocannabinoids
0 references
author
Bernard Le Foll
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
author name string
David A Gorelick
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
Steven R Goldberg
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
publication date
20 March 2009
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
number of pages
4
1 reference
based on heuristic
inferred from page(s)
published in
Psychopharmacology
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
volume
205
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
issue
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
page(s)
171-174
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
exact match
https://scigraph.springernature.com/pub.10.1007/s00213-009-1506-7
0 references
cites work
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabete
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
The role of CB1 receptors in psychostimulant addiction
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Treatment of tobacco dependence: integrating recent progress into practice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Long term pharmacotherapy for obesity and overweight: updated meta-analysis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Obesity and diabetes in the developing world--a growing challenge
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
The endocannabinoid system as an emerging target of pharmacotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Prevalence of overweight and obesity in the United States, 1999-2004
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
How much can treatment reduce national drug problems?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Cannabinoid CB1 receptors control conditioned drug seeking
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Excess deaths associated with underweight, overweight, and obesity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Modulation of anxiety through blockade of anandamide hydrolysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Functional role of high-affinity anandamide transport, as revealed by selective inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
14 September 2017
Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
26 June 2018
A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
3 September 2018
Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
3 September 2018
End of the line for cannabinoid receptor 1 as an anti-obesity target?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
3 September 2018
Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
3 September 2018
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
3 September 2018
Cost-utility analysis of rimonabant in the treatment of obesity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
3 September 2018
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
3 September 2018
Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2695840
retrieved
3 September 2018
Identifiers
DOI
10.1007/S00213-009-1506-7
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
PMC publication ID
2695840
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
PubMed publication ID
19300982
1 reference
stated in
Europe PubMed Central
PMC publication ID
2695840
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300982%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
ResearchGate publication ID
226920163
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
